Healthcare -
Biotechnology - NASDAQ - US
$ 26.33
-8.8 %
$ 2.96 B
Market Cap
-26.07
P/E
VKTX - ACCOUNTS PAYABLE
Accounts Payable VKTX - Viking Therapeutics, Inc.
7.51 M
LAST VALUE
128.08%
2 YEAR CAGR
50.93%
5 YEAR CAGR
58.71%
10 YEAR CAGR